Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Versicolor Technologies is a private biotechnology company focused on skin health applications derived from the human dermal microbiome. The company is developing a postbiotic platform built around Malassezia-derived compounds and related analogs for cosmetic and therapeutic use, particularly in skin aging, pigmentation, and photoprotection. Publicly visible information indicates an early-stage business with patent activity and pre-seed financing rather than a disclosed clinical drug pipeline. Its work appears to sit at the intersection of biotech, dermatology, and consumer skin care, with an emphasis on microbiome-inspired actives. The company is based in Santa Monica/Los Angeles, California.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Versicolor Technologies.